肺癌细胞学标本的分子病理检测:简明综述
该综述总结了细胞学标本在非小细胞肺癌分子检测中的作用,包括标本类型、处理流程、分析前因素对下游分子检测的影响,以及常用的分子检测技术。结论指出,多种细胞学标本类型和制备方式均可进行突变检测,但需理解细胞学工作流程和分子检测背景知识以优化标本使用。
要点
- 细胞学标本常是非小细胞肺癌患者唯一可用于诊断和分子检测的组织样本。
- 多种细胞学标本类型和制备方式均可进行突变检测。
- 需了解标本处理流程和分析前因素对分子检测的影响以优化标本使用。
核心结论
- 突变检测在多种细胞学标本类型和制备方式上是可行的。
- 充分理解细胞学标本处理流程和分子检测背景知识对于标本分流和优化使用是必要的。
研究设计与样本
- 综述类文章,通过PubMed和Google搜索引擎检索已发表文献。
主要发现
- 非小细胞肺癌中已发现多种致癌驱动基因,如表皮生长因子受体(EGFR)突变和间变性淋巴瘤激酶(ALK)基因重排。
- 由于非小细胞肺癌患者常处于晚期, prefer微创技术获取肿瘤样本,包括影像引导活检和细针穿刺。
- 细胞学标本经常是这些患者唯一可用于诊断和分子检测的组织样本。
临床怎么用
- 细胞学标本可用于肺癌突变检测,但需了解标本处理流程和分析前因素对下游分子检测的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: - There has been a paradigm shift in the understanding of molecular pathogenesis of lung cancer. A number of oncogenic drivers have been identified in non-small cell lung carcinoma, such as the epidermal growth factor receptor ( EGFR) mutation and anaplastic lymphoma kinase ( ALK) gene rearrangement. Because of the clinical presentation at an advanced stage of disease in non-small cell lung carcinoma patients, the use of minimally invasive techniques is preferred to obtain a tumor sample for diagnosis. These techniques include image-guided biopsies and fine-needle aspirations, and frequently the cytology specimen may be the only tissue sample available for the diagnosis and molecular testing for these patients. OBJECTIVE: - To review the current literature and evaluate the role of cytology specimens in lung cancer mutation testing. We reviewed the types of specimens received in the laboratory, specimen processing, the effect of preanalytic factors on downstream molecular studies, and the commonly used molecular techniques for biomarker testing in lung cancer. DATA SOURCES: - PubMed and Google search engines were used to review the published literature on the topic. CONCLUSIONS: - Mutation testing is feasible on a variety of cytologic specimen types and preparations. However, a thorough understanding of the cytology workflow for the processing of samples and appropriate background knowledge of the molecular tests are necessary for triaging, and optimum use of these specimens is necessary to guide patient management.
引用
- Jain D, Roy-Chowdhuri S. Molecular Pathology of Lung Cancer Cytology Specimens: A Concise Review. Arch Pathol Lab Med. 2018. PMID: 29547001. doi:10.5858/arpa.2017-0444-RA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。